FORM 8.3 Amendment to Purchase and Sale |
|||||||
IRISH TAKEOVER PANEL |
|||||||
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, |
|||||||
TAKEOVER RULES, 2007 (AS AMENDED) |
|||||||
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES |
|||||||
REPRESENTING 1% OR MORE |
|||||||
1. |
KEY INFORMATION |
||||||
Name of person dealing (Note 1) |
Barclays PLC. |
||||||
Company dealt in |
HORIZON THERAPEUTICS PLC |
||||||
Class of relevant security to which the dealings being disclosed relate (Note 2) |
$0.001 ordinary shares |
||||||
Date of dealing |
07 Jun 2023 |
||||||
2. |
INTERESTS AND SHORT POSITIONS |
||||||
(a) |
Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) |
||||||
Class of relevant security: |
$0.001 ordinary shares |
||||||
|
Long |
Short |
|||||
Number |
(%) |
Number |
(%) |
||||
(1) |
Relevant securities |
1,086,558 |
0.47% |
676,045 |
0.30% |
||
(2) |
Derivatives (other than options): |
140,756 |
0.06% |
98,064 |
0.04% |
||
(3) |
Options and agreements to purchase/sell: |
1,420,000 |
0.62% |
936,400 |
0.41% |
||
TOTAL: |
2,647,314 |
1.16% |
1,710,509 |
0.75% |
|||
(b) |
Interests and short positions in relevant securities of the company, other than the class dealt in |
||||||
Class of relevant security: |
Long |
Short |
|||||
Number |
(%) |
Number |
(%) |
||||
(1) |
Relevant securities |
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
||
(3) |
Options and agreements to purchase/sell: |
|
|
|
|
||
TOTAL: |
|
|
|
|
|||
3. |
DEALINGS (Note 4) |
||||||
(a) |
Purchase and sales |
|
|
|
|
|
|
Class of relevant Security |
Purchase/sale |
Number of securities |
Price per unit |
||||
$0.001 ordinary shares |
Purchase |
4 |
99.9700 USD |
||||
$0.001 ordinary shares |
Purchase |
12 |
99.6200 USD |
||||
$0.001 ordinary shares |
Purchase |
100 |
99.7700 USD |
||||
$0.001 ordinary shares |
Purchase |
183 |
99.6721 USD |
||||
$0.001 ordinary shares |
Purchase |
208 |
100.0011 USD |
||||
$0.001 ordinary shares |
Purchase |
591 |
99.7697 USD |
||||
$0.001 ordinary shares |
Purchase |
625 |
99.7944 USD |
||||
$0.001 ordinary shares |
Purchase |
1,604 |
99.8086 USD |
||||
$0.001 ordinary shares |
Purchase |
2,073 |
99.6980 USD |
||||
$0.001 ordinary shares |
Purchase |
3,349 |
99.4495 USD |
||||
$0.001 ordinary shares |
Purchase |
3,430 |
99.7522 USD |
||||
$0.001 ordinary shares |
Purchase |
3,538 |
99.6777 USD |
||||
$0.001 ordinary shares |
Purchase |
3,819 |
99.7583 USD |
||||
$0.001 ordinary shares |
Purchase |
5,912 |
99.4400 USD |
||||
$0.001 ordinary shares |
Purchase |
9,526 |
99.6036 USD |
||||
$0.001 ordinary shares |
Purchase |
15,500 |
105.0000 USD |
||||
$0.001 ordinary shares |
Purchase |
18,131 |
99.5307 USD |
||||
$0.001 ordinary shares |
Sale |
4 |
99.9700 USD |
||||
$0.001 ordinary shares |
Sale |
15 |
99.8266 USD |
||||
$0.001 ordinary shares |
Sale |
47 |
99.8600 USD |
||||
$0.001 ordinary shares |
Sale |
100 |
99.9350 USD |
||||
$0.001 ordinary shares |
Sale |
100 |
99.4100 USD |
||||
$0.001 ordinary shares |
Sale |
200 |
100.0100 USD |
||||
$0.001 ordinary shares |
Sale |
384 |
99.8183 USD |
||||
$0.001 ordinary shares |
Sale |
536 |
99.7672 USD |
||||
$0.001 ordinary shares |
Sale |
854 |
99.7719 USD |
||||
$0.001 ordinary shares |
Sale |
1,088 |
99.5147 USD |
||||
$0.001 ordinary shares |
Sale |
1,317 |
99.6680 USD |
||||
$0.001 ordinary shares |
Sale |
1,887 |
99.6843 USD |
||||
$0.001 ordinary shares |
Sale |
1,932 |
99.8305 USD |
||||
$0.001 ordinary shares |
Sale |
2,865 |
99.7536 USD |
||||
$0.001 ordinary shares |
Sale |
8,391 |
99.6137 USD |
||||
$0.001 ordinary shares |
Sale |
8,736 |
99.4400 USD |
||||
$0.001 ordinary shares |
Sale |
24,224 |
99.5785 USD |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(b) |
Derivatives transactions (other than option transactions) |
||||||
Product Name |
Nature of transaction |
Number of relevant securities |
Price per unit |
||||
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) |
Options transactions in respect of existing securities |
||||||
(i) |
Writing, selling, purchasing or varying |
||||||
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercising |
|
|
|
|
|
|
Product name |
Number of |
Exercise price |
|||||
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) |
Other dealings (including transactions in respect of new securities) (Note 4) |
||||||
Nature of transaction |
Details |
Price per unit (if applicable) |
|||||
|
|
|
|||||
4. |
OTHER INFORMATION |
||||||
Agreements, arrangements or understandings relating to options or derivatives |
|||||||
Full details of any agreement, arrangement or understanding between the person disclosing |
|||||||
NONE |
|||||||
Is a Supplemental Form 8 (Open Positions) attached? |
YES |
||||||
Date of disclosure: |
15 Jun 2023 |
||||||
Contact name: |
Large Holdings Regulatory Operations |
||||||
Telephone number: |
020 3134 7213 |
||||||
If a connected EFM, name of offeree/offeror with which connected |
|
||||||
If a connected EFM, state nature of connection |
|
||||||
|
|
|
|
|
|
|
|
SUPPLEMENTAL FORM 8 |
|||||||
|
|
|
|
|
|
|
|
IRISH TAKEOVER PANEL |
|||||||
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL |
|||||||
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) |
|||||||
DETAILS OF OPEN POSITIONS |
|||||||
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as |
|||||||
appropriate) |
|||||||
OPEN POSITIONS |
|
|
|
|
|
|
|
Class of relevant |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
|
$0.001 ordinary shares |
Put Options |
Written |
495,500 |
100 |
American |
16 Jun 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
28,800 |
095 |
American |
21 Jul 2023 |
|
$0.001 ordinary shares |
Call Options |
Written |
-10,600 |
105 |
American |
18 Aug 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
2,000 |
085 |
American |
21 Jul 2023 |
|
$0.001 ordinary shares |
Put Options |
Purchased |
-250,000 |
080 |
American |
16 Jun 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
10,200 |
080 |
American |
18 Aug 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
247,500 |
105 |
American |
16 Jun 2023 |
|
$0.001 ordinary shares |
Call Options |
Written |
-2,000 |
100 |
American |
21 Jul 2023 |
|
$0.001 ordinary shares |
Call Options |
Written |
-2,600 |
100 |
American |
18 Aug 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
400,000 |
100 |
American |
18 Aug 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
74,000 |
090 |
American |
15 Sep 2023 |
|
$0.001 ordinary shares |
Put Options |
Purchased |
-544,200 |
080 |
American |
18 Aug 2023 |
|
$0.001 ordinary shares |
Put Options |
Written |
162,000 |
105 |
American |
21 Jul 2023 |
|
$0.001 ordinary shares |
Call Options |
Written |
-10,000 |
105 |
American |
16 Jun 2023 |
|
$0.001 ordinary shares |
Put Options |
Purchased |
-106,800 |
090 |
American |
21 Jul 2023 |
|
$0.001 ordinary shares |
Put Options |
Purchased |
-10,200 |
100 |
American |
18 Aug 2023 |